371 related articles for article (PubMed ID: 3937121)
21. [Antimicrobial activities of clavulanic acid/ticarcillin against clinical isolates].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Dec; 48(12):1899-905. PubMed ID: 8587164
[TBL] [Abstract][Full Text] [Related]
22. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
Traub WH; Spohr M
Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
[TBL] [Abstract][Full Text] [Related]
23. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
Paisley JW; Washington JA
Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792
[TBL] [Abstract][Full Text] [Related]
24. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
Griffin KE; Slocombe B
J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
[No Abstract] [Full Text] [Related]
25. In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.
Gould IM; Dent J; Wise R
J Antimicrob Chemother; 1987 Mar; 19(3):307-12. PubMed ID: 3106304
[TBL] [Abstract][Full Text] [Related]
26. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
Gill CJ; Ponticas S; Shungu DL; Guerriero S
Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
[TBL] [Abstract][Full Text] [Related]
27. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
[TBL] [Abstract][Full Text] [Related]
28. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
30. Comparative in-vitro activities of azlocillin, ticarcillin and ticarcillin plus clavulanic acid against Staphylococcus aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.
Lagast H; Husson M; Klastersky J
J Antimicrob Chemother; 1985 May; 15(5):633-6. PubMed ID: 3924883
[TBL] [Abstract][Full Text] [Related]
31. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
Boon RJ; Beale AS; Sutherland R
Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom.
Lee ML; Tan NH; Fung SY; Sekaran SD
Comp Biochem Physiol C Toxicol Pharmacol; 2011 Mar; 153(2):237-42. PubMed ID: 21059402
[TBL] [Abstract][Full Text] [Related]
33. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
Etesse-Carsenti H; Garraffo R; Bernard E; de Salvador F; Pradier C; Durant J; Mondain V; Drugeon HB; Dellamonica P
Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
[TBL] [Abstract][Full Text] [Related]
34. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the antibacterial activity in vitro of various cephalosporins on different gram-negative bacterial species of recent clinical isolation].
Piccolomini R; Di Sipio L; Ravagnan G
Boll Soc Ital Biol Sper; 1980 Jan; 56(2):133-9. PubMed ID: 6776969
[TBL] [Abstract][Full Text] [Related]
36. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Monteil H; Jehl F
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
38. Timentin and beta-lactamases.
Labia R; Morand A; PĂ©duzzi J
J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
[TBL] [Abstract][Full Text] [Related]
39. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
[TBL] [Abstract][Full Text] [Related]
40. In vitro susceptibility of piperacillin v timentin and ticarcillin.
Bremner DA
N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]